News
Valiant Laboratories consolidated net profit rises 151.43% in the March 2026 quarter
15-May-2026 | 07:36
Sales rise 59.16% to Rs 91.98 crore
Net profit of Valiant Laboratories rose 151.43% to Rs 1.76 crore in the quarter ended March 2026 as against Rs 0.70 crore during the previous quarter ended March 2025. Sales rose 59.16% to Rs 91.98 crore in the quarter ended March 2026 as against Rs 57.79 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 2.20 crore during the previous year ended March 2025. Sales rose 78.04% to Rs 237.47 crore in the year ended March 2026 as against Rs 133.38 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 91.98 | 57.79 | 59 | 237.47 | 133.38 | 78 |
| OPM % | 5.23 | 6.61 | - | 2.69 | -3.50 | - |
| PBDT | 3.97 | 1.46 | 172 | 6.81 | 0.58 | 1074 |
| PBT | 1.05 | 0.94 | 12 | 0.77 | -1.51 | LP |
| NP | 1.76 | 0.70 | 151 | -3.27 | -2.20 | -49 |
Powered by Capital Market - Live News
